title: [Severe mitral regurgitation with ejection fraction below 40%: pharmacologic therapy is the treatment of choice].
abstract: Severe chronic mitral regurgitation with severe left ventricular dysfunction is uncommon. Mitral valve repair is not appropriate and unpredictable in a large proportion of these patients. Mitral valve replacement results in a poor outcome for patients with severe left ventricular dysfunction. Therefore, surgery is not the first therapeutic option for this patient group. Surgery may be considered after optimal medical stabilization and extensive diagnostic evaluation for each individual patient.
authors.affiliation: HerzZentrum Hirslanden, Zürich.
authors.forename: M E
authors.initials: ME
authors.lastname: Rothlin
mesh_terms: D000465:Algorithms; D002908:Chronic Disease; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000601:surgery; D012720:Severity of Illness Index; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000503:physiopathology*
vernacular_title: Schwere Mitralinsuffizienz bei Auswurffraktion unter 40%: Die medikamentöse Behandlung ist die Therapie der Wahl.